Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: Results from the U.S. National Health and Nutrition Examination Survey 1999-2002

Journal of Internal Medicine

Volumn 262, Issue 5, 2007, Pages 562-570

  Kuo, H K ^a,b   Lin, L Y ^a   Yu, Y H ^c,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b National Health and Research Institutes   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cognition; Cross sectional studies; Microalbuminuria; National Health and Nutrition Examination Survey; Peripheral arterial disease

Indexed keywords

ALBUMIN; CREATININE;

AGED; AGING; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BODY MASS; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATION; FEMALE; GENDER; GROUPS BY AGE; HEALTH SURVEY; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; UNITED STATES; URINALYSIS; URINARY EXCRETION;

AGE DISTRIBUTION; AGED; ALBUMINS; ALBUMINURIA; BODY WEIGHTS AND MEASURES; COGNITION; CREATININE; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POPULATION SURVEILLANCE; PSYCHOLOGICAL TESTS; SEX DISTRIBUTION; UNITED STATES;

EID: 35449002453     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01847.x     Document Type: Article

References (40)

1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982 1 : 1430 2.
2. Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl 2004 92 : S22 4.
3. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002 61 : 2165 75.
4. Romundstad S, Holmen J, Kvenild K, Aakervik O, Hallan H. Clinical relevance of microalbuminuria screening in self-reported non-diabetic/non- hypertensive persons identified in a large health screening - the Nord-Trondelag Health Study (HUNT), Norway. Clin Nephrol 2003 59 : 241 51.
5. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006 17 : 2106 11.
6. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997 157 : 1413 8.
7. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 6.
8. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002 106 : 1777 82.
9. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004 110 : 32 5.
10. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005 112 : 969 75.
11. Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001 24 : 1060 5.
12. Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000 36 : 1079 82.
13. Kuo HK, Jones RN, Milberg WP et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc 2005 53 : 1154 61.
14. Iadecola C. Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer's dementia. Arterioscler Thromb Vasc Biol 2003 23 : 1951 3.
15. Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997 349 : 151 4.
16. Prince MJ. Vascular risk factors and atherosclerosis as risk factors for cognitive decline and dementia. J Psychosom Res 1995 39 : 525 30.
17. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993 88 : 837 45.
18. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985 71 : 510 5.
19. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991 20 : 384 92.
20. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998 18 : 185 92.
21. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994 308 : 1604 8.
22. Phillips NA, Mate-Kole CC. Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects. Stroke 1997 28 : 777 84.
23. Waldstein SR, Tankard CF, Maier KJ et al. Peripheral arterial disease and cognitive function. Psychosom Med 2003 65 : 757 63.
24. Slooter AJ, van Duijn CM, Bots ML et al. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. J Neural Transm Suppl 1998 53 : 17 29.
25. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999 282 : 40 6.
26. 1999-2000 National Health and Nutrition Examination Survey (NHANES). Bethesda, MD : National Center for Health Statistics. http://www.cdc.gov/nchs/ about/major/nhanes/nhanes99_00.htm. Accessed 11 July, 2007.
27. 2001-2002 National Health and Nutrition Examination Survey (NHANES). Bethesda, MD : National Center for Health Statistics. http://www.cdc.gov/nchs/ about/major/nhanes/nhanes01-02.htm. Accessed 11 July, 2007.
28. Chavers BM, Simonson J, Michael AF. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 1984 25 : 576 8.
29. Eknoyan G, Hostetter T, Bakris GL et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003 42 : 617 22.
30. Lower Extremity Disease Procedures Manual. Bethesda, MD : National Center for Health Statistics. http://www.cdc.gov/nchs/data/nhanes/le.pdf. Accessed 11 July, 2007.
31. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York : The Psychological Corporation, 1981.
32. Vilkki J, Holst P. Mental programming after frontal lobe lesions: results on digit symbol performance with self-selected goals. Cortex 1991 27 : 203 11.
33. Parkin AJ, Java RI. Deterioration of frontal lobe function in normal aging: influences of fluid intelligence versus perceptual speed. Neuropsychology 1999 13 : 539 45.
34. National Heart L, and Blood Institute. Obesity Education Initiative: The Evidence Report. Bethesda, MD : Nation Institutes of Health, 1998.
35. de Luis DA, Fernandez N, Arranz M, Aller R, Izaola O. Total homocysteine and cognitive deterioration in people with type 2 diabetes. Diabetes Res Clin Pract 2002 55 : 185 90.
36. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996 27 : 2033 9.
37. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004 255 : 247 56.
38. Wada M, Nagasawa H, Kurita K et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 2007 255 : 27 34.
39. Pugh KG, Lipsitz LA. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002 23 : 421 31.
40. Zuccala G, Onder G, Marzetti E et al. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005 26 : 226 33.